Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Recently updated

FDA-approved

Showing page 99 of 200 · By data quality, then INN

  1. repotrectinib

    AUGTYRO

    ORAL FDA: approved · EMA: approved · PMDA: approved · NMPA: clinical trials

    L01EX28

  2. rescinnamine

    CINNASIL

    ORAL FDA: approved

  3. retifanlimab-dlwr

    ZYNYZ

    INTRAVENOUS FDA: approved

  4. revefenacin

    REVEFENACIN

    INHALATION FDA: approved · NMPA: clinical trials

  5. rezafungin acetate

    REZZAYO

    INTRAVENOUS FDA: approved

  6. ribociclib

    KISQALI Novartis Pharmaceuticals

    ORAL FDA: approved · EMA: approved · TGA: approved

    L01EF02

  7. ribociclib succinate

    KISQALI

    ORAL FDA: approved

  8. riboflavin 5'-phosphate

    PHOTREXA VISCOUS IN DEXTRAN 20%

    OPHTHALMIC FDA: approved

  9. riboflavin 5'-phosphate sodium

    PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA

    OPHTHALMIC FDA: approved

  10. rifabutin

    MYCOBUTIN Pfizer Australia Pty Ltd

    ORAL FDA: approved · TGA: approved

  11. rifamycin sodium

    AEMCOLO

    ORAL FDA: approved

  12. rifapentine

    PRIFTIN

    ORAL FDA: approved · NMPA: clinical trials

  13. rifaximin

    XIFAXAN Norgine Pty.

    ORAL FDA: approved · TGA: approved · NMPA: clinical trials

  14. rilpivirine

    EDURANT Janssen-Cilag Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved

    J05AG05

  15. rilpivirine hydrochloride

    RILPIVIRINE HYDROCHLORIDE

    ORAL FDA: approved

  16. rilzabrutinib

    WAYRILZ

    ORAL FDA: approved · EMA: approved · NMPA: clinical trials

    Not yet assigned

  17. rimantadine hydrochloride

    RIMANTADINE HYDROCHLORIDE

    ORAL FDA: approved

  18. rimegepant

    VYDURA

    ORAL FDA: approved · EMA: approved

    N02CD06

  19. rimegepant sulfate

    NURTEC ODT

    ORAL FDA: approved

  20. rimexolone

    VEXOL

    OPHTHALMIC FDA: approved

  21. ripretinib

    QINLOCK

    ORAL FDA: approved · EMA: approved · TGA: approved

    L01

  22. risankizumab-rzaa

    SKYRIZI

    INJECTION FDA: approved

  23. risdiplam

    EVRYSDI Hoffmann-La Roche

    ORAL FDA: approved · EMA: approved · TGA: approved

    M09AX10

  24. ritlecitinib tosylate

    LITFULO

    ORAL FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.